Superbugs Win Another Round As Big Pharma Leaves Antibiotics

July 13, 2018 | The fight against life-threatening infections suffered another blow when one of the world's biggest drugmakers waved the white flag. Novartis is the latest drug giant to end antibacterial and antiviral research, joining the like of AstraZeneca, Sanofi, and Allergan. Bloomberg